#TDP43
VectorY Therapeutics expanded the PIONEER-ALS trial from 12 to 36 participants to test VTx-002, an antibody targeting TDP-43 protein aggregates found in 97% of patients.

#ALS #TDP43 #AntibodyTherapy
PIONEER-ALS enrollment expands before efficacy data
Source: Longevity.Technology
realfeedapp.com
October 19, 2026 at 6:00 PM
The authors included RRIDs in their in Biophysical Chemistry paper! RRIDs improve reproducibility in scientific research. #OpenScience #STMpublishing #ReproducibleResearch
Small heat shock protein HSPB8 interacts with a pre-fibrillar TDP43 low complexity domain species to delay fibril formation
Read the full paper: Small heat shock protein HSPB8 interacts with a pre-fibrillar TDP43 low complexity domain species to delay fibril formation
doi.org
October 9, 2026 at 7:12 AM
Nucleoporin 50 rescues hallmarks of #TDP43 proteinopathy in #ALS/FTD disease models

Courtney L. Smith, Bilal Khalil, Alyssa C. Walker... Wilfried Rossoll @rossolllab.bsky.social @mayoclinic.org #FrontotemporalDementia

link.springer.com/article/10.1...
October 8, 2026 at 4:55 PM
In vivo detection of pathologic α- #synuclein and #TDP43 in the skin and olfactory mucosa of a patient with #Parkinsons disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation

Paola Caroppo, Vittoria Aprea...Grazia Devigili

link.springer.com/article/10.1...
In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson’s disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation - Molecular Neu...
We describe a patient carrying the GRN p.Thr272Serfs*10 mutation, who presented with parkinsonism at onset and later developed prodromal frontotemporal dementia, in whom seed amplification assay on ol...
link.springer.com
October 5, 2026 at 2:16 PM
Out of 10 IDRs, 8 colocalized indiscriminately, whereas
TDP43 and UBQ2 formed spatially distinct condensates. In TDP43 a segment forming a transient α-helix (see work by @nicolasluxfawzi.bsky.social) determined self-recognition specificity as a truncated mutant co-localized with all other IDRs.
September 25, 2026 at 12:25 PM
As part of our inaugural review series!

Targeting protein aggregate co-pathologies in #neurodegeneration: a viable therapeutic strategy?

Silas A. Buck, Sidharth S. Madhavan, Laurie H. Sanders
@dukemedschool.bsky.social #TDP43 #tauopathy #amyloid #alphasynuclein

link.springer.com/article/10.1...
Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy? - Molecular Neurodegeneration Advances
Many neurodegenerative diseases are characterized by pathological protein aggregation in the brain. Alzheimer’s disease displays amyloid-β and tau inclusions in the form of amyloid-β plaques and tau n...
link.springer.com
September 23, 2026 at 3:46 PM
Authors used pDuet TDP43 WT from @addgene.bsky.social in their study. Including #RRIDs will make this less ambiguous.

SciScore made a table with this resource, see “Automated Services” module (download as csv, xml or #jats) #OpenScience #reproducibility
www.biorxiv.org
September 8, 2026 at 12:00 PM
In mouse cortex, developmental TDP-43 expression disrupted long-range projection patterns; expression after birth shortened axons and reduced branching.

https://doi.org/10.1016/j.neures.2026.105079
#NeuroscienceResearch #Neuroscience #TDP43
August 31, 2026 at 11:15 AM
ALSに関わるTDP-43の異常は、軸索を作る時期と、できた後で同じ影響を及ぼすのでしょうか。マウス皮質では、発達期には長距離投射の配置が乱れ、出生後には軸索が短くなって分岐が減りました。

https://doi.org/10.1016/j.neures.2026.105079
#NeuroscienceResearch #Neuroscience #TDP43
August 31, 2026 at 11:15 AM
This Review proposes #TDP43-associated neurodegenerative disease as a staging framework that links presymptomatic biology with later clinical phenotypes and could support earlier mechanism-based treatment development. ja.ma/4g487c8
August 24, 2026 at 3:00 PM
This JAMA Neurology #Review proposes #TDP43-associated neurodegenerative disease as a staging framework that links presymptomatic biology with later clinical phenotypes and could support earlier mechanism-based treatment development. ja.ma/4g487c8
TDP-43–Associated Neurodegenerative Disease
This narrative review discusses an alternative approach to disease classification based on underlying pathobiology, specifically examining the role of transactive response DNA-binding protein, 43 kDa ...
ja.ma
August 24, 2026 at 4:42 PM
Progressive cytoplasmic mislocalization of TDP-43 across neuronal aging stages

I am sharing a data visualization intended to communicate a well-documented trend in TDP-43 proteostasis.

#TDP43 #Proteostasis #Neurodegeneration #Nucleocytoplasmic #DataVisualization #Proteinopathy
August 11, 2026 at 5:00 PM
interesting work on als mechs in *not* MNs. proprioceptive sensory degeneration in SOD1 and TDP43 transgenic mice. http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002/cne.23906
December 7, 2024 at 12:35 AM
APPA Joint Session- Yun-Ru (Ruby) Chen. Welcomes everyone to APPA in Singapore in 2028! Neurodegenerative Disease. TDP proteinopathies, not thioflavin T positive. Forms soluble aggregate. Conformational antibody to detect amyloid. Translational therapeutic development in progress. #LorneProteins2025
February 10, 2025 at 10:13 PM
https://gregory-ms.com/articles/280474/
Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects

#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #NeuroSkyence
June 2, 2024 at 4:10 PM
I wonder how specific this may be to ALS? Aging also causes Tdp43 dysfunction (risk of ALS increases w age) www.nature.com/articles/s42... so perhaps this is more about importance of CoxIV to motoneuron survival than ALS per se?
Age-related demethylation of the TDP-43 autoregulatory region in the human motor cortex - Communications Biology
In order to assess the effects of aging on the autoregulation of TAR DNA-binding protein 43 (TDP-43) and the potential effects of this on the role of TDP-43 in Amyotrophic Lateral Sclerosis (ALS), Koi...
www.nature.com
March 15, 2025 at 7:06 PM
April 3, 2025 at 4:17 PM
Join @uwmadison.bsky.social and #CLARiTI for "Advancing TDP-43 Biomarkers: From Discovery to Application," a virtual summit exploring cutting-edge biomarker research.
📅 June 12
✅ RSVP at go.wisc.edu/92qiel to gain insights from top researchers shaping the future of neurodegenerative disease research
2025 Summit Advancing TDP43 Biomarkers: From Discovery to Application | Alzheimer's Disease Research Center
RSVP today to join Drs. Henrik Zetterberg, Hartmuth Kolb and Sterling Johnson for the 2025 Summit Advancing TDP43 Biomarkers: From Discovery to Application, hosted by the University of Wisconsin–Madis...
go.wisc.edu
April 28, 2025 at 7:56 PM